Alembic Pharma gets USFDA EIR for 2 API facilities in Panelav
Vadodara: Alembic Pharma has announced that the Company has received Establishment Inspection Report (EIR) for the inspection carried out by the US Food and Drug Administration (USFDA) at its API – I & API – II Facility located at Panelav. The EIR follows the inspection conducted from 26th May, 2025 to 31st May, 2025. During the inspection, the […]